| 101 |
25586740 | MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathway. | 2015 May |
1 |
| 102 |
25843419 | Dasatinib enhances cisplatin sensitivity in human esophageal squamous cell carcinoma (ESCC) cells via suppression of PI3K/AKT and Stat3 pathways. | 2015 Jun 1 |
1 |
| 103 |
25867391 | Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro. | 2015 Mar 30 |
2 |
| 104 |
23661500 | SERPINB2 down-regulation contributes to chemoresistance in head and neck cancer. | 2014 Oct |
2 |
| 105 |
24659656 | Suppression of STAT3 by chemically modified siRNAs increases the chemotherapeutic sensitivity of parental and cisplatin-resistant non-small cell lung cancer cells. | 2014 Jan-Mar |
3 |
| 106 |
24944268 | Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation. | 2014 Aug 15 |
1 |
| 107 |
25213670 | Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC. | 2014 Nov |
2 |
| 108 |
25514838 | WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis. | 2014 Dec 17 |
1 |
| 109 |
23149124 | Silencing of the transcription factor STAT3 sensitizes lung cancer cells to DNA damaging drugs, but not to TNFα- and NK cytotoxicity. | 2013 Feb 15 |
1 |
| 110 |
23319321 | Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer. | 2013 Jan |
2 |
| 111 |
23426872 | Regulation of AKT gene expression by cisplatin. | 2013 Mar |
3 |
| 112 |
23427943 | Simultaneous suppression of Src and signal transducer and activator of transcription 3 inhibits the growth of epithelial ovarian cancer cells. | 2013 Jul |
1 |
| 113 |
23436796 | Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment. | 2013 Apr 15 |
1 |
| 114 |
23526220 | Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway. | 2013 Aug |
3 |
| 115 |
23546174 | Overexpression of AKT decreases the chemosensitivity of gastric cancer cells to cisplatin in vitro and in vivo. | 2013 May |
3 |
| 116 |
23665025 | Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells. | 2013 May 31 |
3 |
| 117 |
23962558 | Abrogation of constitutive Stat3 activity circumvents cisplatin resistant ovarian cancer. | 2013 Dec 1 |
7 |
| 118 |
23969971 | Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer. | 2013 Aug |
7 |
| 119 |
24083752 | AZD1480 can inhibit the biological behavior of ovarian cancer SKOV3 cells in vitro. | 2013 |
1 |
| 120 |
21875334 | A potent oncolytic adenovirus selectively blocks the STAT3 signaling pathway and potentiates cisplatin antitumor activity in ovarian cancer. | 2012 Jan |
1 |
| 121 |
21909139 | Hyperactive EGF receptor, Jaks and Stat3 signaling promote enhanced colony-forming ability, motility and migration of cisplatin-resistant ovarian cancer cells. | 2012 May 3 |
6 |
| 122 |
22104727 | Inhibition of activated Stat3 reverses drug resistance to chemotherapeutic agents in gastric cancer cells. | 2012 Feb 28 |
1 |
| 123 |
22280969 | Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). | 2012 Jan 26 |
3 |
| 124 |
22847808 | Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. | 2012 Sep 15 |
2 |
| 125 |
22961117 | Inhibition of the JAK-STAT3 signaling pathway by ganoderic acid A enhances chemosensitivity of HepG2 cells to cisplatin. | 2012 Nov |
2 |
| 126 |
21885917 | HO-3867, a curcumin analog, sensitizes cisplatin-resistant ovarian carcinoma, leading to therapeutic synergy through STAT3 inhibition. | 2011 Nov 1 |
1 |
| 127 |
20127005 | Expression of Stat3 and Notch1 is associated with cisplatin resistance in head and neck squamous cell carcinoma. | 2010 Mar |
5 |
| 128 |
19427998 | STI571 sensitizes breast cancer cells to 5-fluorouracil, cisplatin and camptothecin in a cell type-specific manner. | 2009 Aug 1 |
1 |
| 129 |
19623660 | Hypoxia induces chemoresistance in ovarian cancer cells by activation of signal transducer and activator of transcription 3. | 2009 Nov 1 |
1 |
| 130 |
18196976 | NCX-4016, a nitro-derivative of aspirin, inhibits EGFR and STAT3 signaling and modulates Bcl-2 proteins in cisplatin-resistant human ovarian cancer cells and xenografts. | 2008 Jan 1 |
1 |
| 131 |
18059167 | Inhibition of Stat3 activity by YC-1 enhances chemo-sensitivity in hepatocellular carcinoma. | 2007 Dec |
4 |
| 132 |
15592503 | In vivo antitumor efficacy of STAT3 blockade using a transcription factor decoy approach: implications for cancer therapy. | 2005 Feb 3 |
3 |
| 133 |
15643501 | Overexpression of constitutive signal transducer and activator of transcription 3 mRNA in cisplatin-resistant human non-small cell lung cancer cells. | 2005 Feb |
3 |
| 134 |
15010843 | Modulation of Janus kinase 2 by cisplatin in cancer cells. | 2004 Apr |
1 |
| 135 |
10978511 | Structure and functional analysis of the human STAT3 gene promoter: alteration of chromatin structure as a possible mechanism for the upregulation in cisplatin-resistant cells. | 2000 Sep 7 |
4 |